• Print Print
  • Share
  • Text Size: A | A | A
Joseph J. Perry, MD is a doctor in Walla Walla, WA specializing in internal medicine, cardiovascular disease and interventional cardiology.

Joseph J. Perry, MD

Specialties

Cardiology
Accepting new patients

Board Certification

  • Cardiovascular Disease
  • Internal Medicine
  • Interventional Cardiology
401 W. Poplar Street
Walla Walla, WA 99362
P: (509) 897-2600
F: (509) 897-5747

Philosophy of Care

Always do what's best for the patient.

Schedule an Appointment Now

Have you seen Dr. before?
Yes
No
What type of appointment? I would like to see my doctor about something we’ve already discussed.
Follow-Up
I am an existing patient and would like to see my doctor for a preventative visit.
Annual Wellness
I need to see my doctor about a non-urgent, but new health issue
New Condition


browser upgrade

Overview

Gender

Male

Licenses

  • Arizona
  • Idaho
  • Kansas
  • Utah
  • South Dakota
  • Washington

Expertise

Education

Medical School

University of Utah School of Medicine - Salt Lake City, UT

Internship

LDS Hospital - Salt Lake City, UT

Residency

LDS Hospital - Salt Lake City, UT

Fellowship

University of Utah School of Medicine - Salt Lake City, UT

Achievements

Publications

Perry, J.J., Hackett, T.N., Bray, P.F. et al: "Laboratory Diagnosis of Multiple Sclerosis." Rocky Mountain Medicine Journal 70 (7) 42-44, 1973.

Bray, P.F., Perry, J.J., Hackett, T.N., et al: "Laboratory Confirmation of Multiple Sclerosis on a drop of Cerebrospinal Fluid." Connecticut Medicine 28 (8) 423-424, 1974.

Perry, J.J., Bray, P.F., Hackett, T.N.: "Comparison of Electroimmunodiffusion for Measurement of IgG in the Laboratory Diagnosis of Multiple Sclerosis, Clinical Chemistry 20: 1411-1443, 1974.

4.Cheung, L.Y., Lowrey, S.F., Perry, J.J., et al: Topical Effects of 16, 16 Dimethyl PGE2 on Gastric Acid Secretion and Mucosal Permeability to Hydrogen Ions in Dogs." GUT 19 (9): 775-778, September 1978.

Topol E and the GUSTO Investigators: "An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction," New England Journal of Medicine, 329:673-682, 1993.

Ross, A.M. and the GUSTO Angiographic Investigators: "The Effects of Tissue Plasminogen Activator, Streptokinase, or both on coronary artery patency, ventricular function, and Survival after Acute Myocardial Infarction." New England Journal of Medicine, 329:1615-1622, 1993.

Topol E and the GUSTO IIb Investigators: "A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes," New England Journal of Medicine, 335:775-782, (September 12), 1996

Waldo Al, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP and the SWORD Investigators: "Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction," The Lancet, Vol. 348, No. 9019, Pages 7-12, (Saturday 6 July), 1996 

Betrieu, A; Phillips, H.; Ellis, S; and the GUSTO IIb Investigators: "A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial Infarction," New England Journal of Medicine, 336:1621-1628, (June 5) 1997.

GUSTO III Investigators: "A Comparison of Reteplase with Alteplase for Acute Myocardial Infarction," New England Journal of Medicine, 337:1118- 1123, (October 16) 1997

Ross, A.M., Coyne, K.S., Reiner, J.S., et al.: "A Randomized Trial Comparing Primary Angioplasty With a Strategy of Short-Acting Thrombolysis and Immediate Planned Rescue Angioplasty in Acute Myocardial Infarction: The PACT Trial." Journal of the American College of Cardiology, 34: 1954- 1962, (December) 1999

Cohn, J.A., Tognani, G for the Valsartan Heart Failure Trial Investigators: "A Randomized Trial of the Angiotensin Receptor Blocker Valsartan in Chronic Heart Failure," NEJM 345:1667, December 6, 2001

Dahlof, B., Devereux, R.B., Kjeldsen, S.E., et al.: "Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol," The Lancet, 359: 995-1003, March 23, 2002

Lindholm, L.H., Ibsen, H., Dahlof, B. et al., "Cardiovascular Morbidity and Mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol," The Lancet, 359: 1004-1010, March 23, 2002

Kjeldsen, S.E., Dahlof, B., Devereux, R. B et al.., "Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients with Isolated Systolic Hypertension and Left Ventricular Hypertrophy." JAMA, 288:1491, September 25, 2002

Abstracts, Letters, Etc.

Cheung, L.Y., Perry, J.J., Moody, F.G.: "Effect of Prostaglandin E on Gastric Mucosal Permeability to H+." Presented at the Tripartite Meeting of University Surgeons, September 1976, Philadelphia, PA.

Perry, J.J.: "3’5’ Cycle AMP Concentration in Cerebrospinal Fluid of Patients with Prolonged Coma." (Letter) New England Journal of Medicine, 296:56, 1977.

Perry, J.J.: "Coronary Angiography," video production, International Television Production, Inc., 1985 

Perry, J.J.: "Prehospital initiated vs Hospital initiated Thrombolytic Therapy for Acute Myocardial Infarction," (letter) JAMA, 271, 6:426, 1994.

Lundergan, C.F., Reiner, J.S., Perry, J.J., Ross, A.M.: "Effect of Body Weight and (etc.)." Presented at 68th Scientific Session, American Heart Association, November 1995. Anaheim, California.

Professional Organizations

  • American College of Cardiology (Fellow)

Interests

Medical Interests

Coronary and vascular intervention, pacemakers, defibrillators and nuclear cardiology.

Personal Interests

Writing fiction, bicycling, mountain sports and photography.

1851321442